Grupo de Genética de Micobacterias, Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza IIS-Aragón, Zaragoza, Spain.
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Microbiol Spectr. 2023 Jun 15;11(3):e0534422. doi: 10.1128/spectrum.05344-22. Epub 2023 Mar 29.
A bedaquiline-resistant Mycobacterium abscessus isolate was sequenced, and a candidate mutation in the gene was identified as responsible for the antibiotic resistance phenotype. To establish a direct genotype-phenotype relationship of this mutation which results in a Asp-to-Ala change at position 29 (D29A), we developed a recombineering-based method consisting of the specific replacement of the desired mutation in the bacterial chromosome. As surrogate bacteria, we used two M. abscessus bedaquiline-susceptible strains: ATCC 19977 and the SL541 clinical isolate. The allelic exchange substrates used in recombineering carried either the sole D29A mutation or a genetic barcode of silent mutations in codons flanking the D29A mutation. After selection of bedaquiline-resistant M. abscessus colonies transformed with both substrates, we obtained equivalent numbers of recombinants. These resistant colonies were analyzed by allele-specific PCR and Sanger sequencing, and we demonstrated that the presence of the genetic barcode was linked to the targeted incorporation of the desired mutation in its chromosomal location. All recombinants displayed the same MIC to bedaquiline as the original isolate, from which the D29A mutation was identified. Finally, to demonstrate the broad applicability of this method, we confirmed the association of bedaquiline resistance with the A64P mutation in analysis performed in independent M. abscessus strains and by independent researchers. Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by microorganisms. On the other hand, infections caused by affect people with chronic lung diseases, and their incidence has grown alarmingly in recent years. Further, these bacteria are known to easily develop AMR to the few therapeutic options available, making their treatment long-lasting and challenging. The recent introduction of new antibiotics against , such as bedaquiline, makes us anticipate a future when a plethora of antibiotic-resistant strains will be isolated and sequenced. However, in the era of whole-genome sequencing, one of the challenges is to unequivocally assign a biological function to each identified polymorphism. Thus, in this study, we developed a fast, robust, and reliable method to assign genotype-phenotype associations for putative antibiotic-resistant polymorphisms in .
一株耐贝达喹啉的脓肿分枝杆菌分离株被测序,发现基因中的一个候选突变是导致抗生素耐药表型的原因。为了建立这种突变的直接基因型-表型关系,导致位置 29(D29A)的天冬氨酸到丙氨酸的变化,我们开发了一种基于重组的方法,包括在细菌染色体中特异性替换所需的突变。作为替代细菌,我们使用了两种脓肿分枝杆菌贝达喹啉敏感株:ATCC 19977 和 SL541 临床分离株。重组中使用的等位基因交换底物要么仅携带 D29A 突变,要么携带 D29A 突变侧翼密码子中的沉默突变的遗传条码。在用两种底物转化的耐贝达喹啉的脓肿分枝杆菌菌落中进行选择后,我们获得了数量相等的重组体。这些耐药菌落通过等位基因特异性 PCR 和 Sanger 测序进行分析,我们证明了遗传条码的存在与所需突变在其染色体位置的靶向整合有关。所有重组体的贝达喹啉 MIC 与最初分离的 D29A 突变相同。最后,为了证明该方法的广泛适用性,我们在独立的脓肿分枝杆菌菌株和独立研究人员的分析中证实了贝达喹啉耐药与 64P 突变的关联。抗生素耐药性(AMR)威胁着越来越多的由微生物引起的感染的有效预防和治疗。另一方面,由引起的感染会影响患有慢性肺部疾病的人群,近年来其发病率急剧上升。此外,这些细菌很容易对现有的少数治疗选择产生 AMR,使其治疗变得持久且具有挑战性。最近引入了针对的新型抗生素,如贝达喹啉,这让我们预计未来会有大量的抗生素耐药菌株被分离和测序。然而,在全基因组测序时代,面临的挑战之一是明确为每个鉴定的多态性赋予生物学功能。因此,在这项研究中,我们开发了一种快速、稳健和可靠的方法,用于确定在中潜在抗生素耐药多态性的基因型-表型关联。